通过代谢工程和改进的发酵技术,在肝素素生产方面取得了进展
Li-Li Sheng1, Yi-Min Cai1, Yi Li1
1Key Laboratory of Chemical Biology of Natural Products, Ministry of Education, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
Carbohydrate polymers
|February 22, 2024
概括
肝素的微生物工程提供了一个可扩展的,具有成本效益的肝素生产替代方案. 代谢工程策略可以提高肝素的产量,并控制治疗应用的分子量.
科学领域:
- 生物技术是生物技术.
- 合成生物学 合成生物学
- 生物化学 生物化学
背景情况:
- 氨酸是一种重要的抗凝血剂和抗血栓剂,在临床上使用了近一个世纪.
- 氨酸的新兴治疗应用包括治疗炎症,癌症和COVID-19等传染病.
- 从动物组织中提取传统的肝素在成本和可扩展性方面面临限制.
研究的目的:
- 审查微生物素生物合成和代谢工程策略.
- 分析增强肝素素生产和控制分子重量的方法.
- 讨论生物工程肝素的扩大规模,挑战和未来前景.
主要方法:
- 微生物肝素生物合成中的关键模块的分析.
- 对提高产量和调节分子重量的代谢工程策略的审查.
- 检查发酵规模的优化技术.
主要成果:
- 代谢工程的进步导致了微生物细胞工厂中高产的肝素素生产.
- 肝素素作为生物工程肝素的化学酶合成的关键前体,具有定义的分子量分布.
- 工程微生物系统提供了一个可扩展和具有成本效益的途径,以肝素前体.
结论:
- 微生物生产的肝素是一种有前途的替代动物衍生的肝素.
- 代谢工程提供了强大的工具,以优化治疗应用的肝素素生产.
- 需要进一步的研究来应对扩大规模的挑战,并充分实现生物工程肝素的潜力.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


